Comparing the Top Two: China Pharma Holdings, Inc. (NYSE:CPHI), PTC Therapeutics, Inc. (NASDAQ:PTCT)

stock recommendation

China Pharma Holdings, Inc. (NYSE:CPHI)

China Pharma Holdings, Inc. (NYSE:CPHI) closed at $0.29 on the last trading session with an decrease of -3.45%, whereas, it previously closed at $0.3. The company has a market capitalization of $11.33 Million. The company traded shares of 480773 on the trading day while its three month average volume stands at 301.96 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of China Pharma Holdings, Inc. (NYSE:CPHI) produced diluted EPS of -0.22. The EPS estimate for next year as estimated by analysts is at 0 while EPS for next quarter is estimated at 0. Earnings per Share growth for this year is reported at 44.2, while the analysts estimated the EPS growth for next year at 0% and Earnings growth for next 5 years stands at 10% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 11.7%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of China Pharma Holdings, Inc. (NYSE:CPHI) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of China Pharma Holdings, Inc. (NYSE:CPHI) stands at 1.02 and Price to Book or P/B for the most recent quarter stands at 0.47. The Price to Free Cash Flow ratio or P/FCF is reported at 7.08. The quick ratio and the current ratio of China Pharma Holdings, Inc. (NYSE:CPHI) are reported at 0.2 and 0.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for China Pharma Holdings, Inc. (NYSE:CPHI) stands at -22, -32.6 and -27.1 respectively

The trailing twelve month Revenue of China Pharma Holdings, Inc. (NYSE:CPHI) is reported at 11.1 Million with income of -9500000. The outstanding shares of China Pharma Holdings, Inc. (NYSE:CPHI) are 38.62 Million. The institutional Ownership of the shares of 2.1 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of China Pharma Holdings, Inc. (NYSE:CPHI) is ticked at 0.3%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for China Pharma Holdings, Inc. (NYSE:CPHI) is the Mean Target Price estimated by the analysts which stands at 3. The 52 week high of China Pharma Holdings, Inc. (NYSE:CPHI) is placed at 0.58 and 52 week low is standing at 0.21.

Performance wise the shares of China Pharma Holdings, Inc. (NYSE:CPHI) fell down -0.68% for the week, it also rise 19.8% for the monthly performance, while for the quarter it went down 14.82%. The shares increase 6.26% for the half year and flew up for the Year-To-Date performance. The shares of China Pharma Holdings, Inc. (NYSE:CPHI) grew 1.21% for the yearly performance.

PTC Therapeutics, Inc. (NASDAQ:PTCT)

PTC Therapeutics, Inc. (NASDAQ:PTCT) closed at $52.47 on the last trading session with an increase of 1.88%, whereas, it previously closed at $51.5. The company has a market capitalization of $3.34 Billion. The company traded shares of 931992 on the trading day while its three month average volume stands at 720.06 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) produced diluted EPS of -4.06. The EPS estimate for next year as estimated by analysts is at -1.6 while EPS for next quarter is estimated at -0.56. Earnings per Share growth for this year is reported at -36.4, while the analysts estimated the EPS growth for next year at -1.6% and Earnings growth for next 5 years stands at -9.51% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 11.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of PTC Therapeutics, Inc. (NASDAQ:PTCT) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of PTC Therapeutics, Inc. (NASDAQ:PTCT) stands at 11.26 and Price to Book or P/B for the most recent quarter stands at 4.47. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of PTC Therapeutics, Inc. (NASDAQ:PTCT) are reported at 4.3 and 4.4 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for PTC Therapeutics, Inc. (NASDAQ:PTCT) stands at -16.7, -44.1 and -23 respectively

The trailing twelve month Revenue of PTC Therapeutics, Inc. (NASDAQ:PTCT) is reported at 296.9 Million with income of -222200000. The outstanding shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) are 63.73 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 0.13 in the last six months. The insider ownership for the shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) is ticked at 0.1%, the figure is plummeted -69.67% in the last six months.

Some other important financial aspects to be discussed here for PTC Therapeutics, Inc. (NASDAQ:PTCT) is the Mean Target Price estimated by the analysts which stands at 55.89. The 52 week high of PTC Therapeutics, Inc. (NASDAQ:PTCT) is placed at 53.29 and 52 week low is standing at 27.53.

Performance wise the shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) rose up 0.46% for the week, it also rise 8.3% for the monthly performance, while for the quarter it went down 45.33%. The shares increase 19.28% for the half year and flew up for the Year-To-Date performance. The shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) grew 50.47% for the yearly performance.